BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: EL-Awady MK, Tabll AA, Atef K, Yousef SS, Omran MH, El-Abd Y, Bader-Eldin NG, Salem AM, Zohny SF, El-Garf WT. Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro. World J Gastroenterol 2006; 12(16): 2530-2535 [PMID: 16688798 DOI: 10.3748/wjg.v12.i16.2530]
URL: https://www.wjgnet.com/1007-9327/full/v12/i16/2530.htm
Number Citing Articles
1
Huma Tariq, Sobia Manzoor, Fahed Parvaiz, Farakh Javed, Kaneez Fatima, Ishtiaq Qadri. An overview: In vitro models of HCV replication in different cell culturesInfection, Genetics and Evolution 2012; 12(1): 13 doi: 10.1016/j.meegid.2011.10.009
2
Ahmed Atef Mesalam, Isabelle Desombere, Ali Farhoudi, Freya Van Houtte, Lieven Verhoye, Jonathan Ball, Jean Dubuisson, Steven K.H. Foung, Arvind H. Patel, Mats A.A. Persson, Geert Leroux-Roels, Philip Meuleman. Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1Virology 2018; 514: 30 doi: 10.1016/j.virol.2017.10.019
3
Sidra Rehman, Usman Ali Ashfaq, Bushra Ijaz, Sheikh Riazuddin. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cellsMicrobial Pathogenesis 2018; 121: 198 doi: 10.1016/j.micpath.2018.05.023
4
Mohamed Abbas Shemis, Dina Mohamed El-Abd, Dalia Ibrahim Ramadan, Mohamed Ibrahim El-Sayed, Bassem Shenoda Guirgis, Mohamed Ali Saber, Hassan Mohamed El-Said Azzazy. Evaluation of Multiplex Nested Polymerase Chain Reaction for Routine Hepatitis C Virus Genotyping in Egyptian PatientsHepatitis Monthly 2012; 12(4): 265 doi: 10.5812/hepatmon.6012
5
Noha Gamal Bader El Din, Ghada M. Salum, Mohamed A. Anany, Marwa Khalil Ibrahim, Reham Mohamed Dawood, Naglaa Zayed, Yasmine S. El Abd, Reem El-Shenawy, Mostafa K. El Awady. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian PatientsJournal of Interferon & Cytokine Research 2015; 35(8): 641 doi: 10.1089/jir.2014.0137
6
Imran Shahid, Waleed Hassan Almalki, Munjed M. Ibrahim, Sultan Ahmad Alghamdi, Mohammed H. Mukhtar, Shaia Saleh R. Almalki, Saad Ahmed Alkahtani, Mohammad S. Alhaidari. Characterization of In vitro Inhibitory Effects of Consensus Short Interference RNAs against Non-Structural 5B Gene of Hepatitis C Virus 1a GenotypeIndian Journal of Medical Microbiology 2018; 36(4): 494 doi: 10.4103/ijmm.IJMM_17_146
7
Ashraf A. Tabll, Samy B. Khalil, Reem M. El‐Shenawy, Gamal Esmat, Amr Helmy, Abdel Fattah Attallah, Mostafa K. El‐Awady. Establishment of Hybrid Cell Lines Producing Monoclonal Antibodies to a Synthetic Peptide from the E1 Region of the Hepatitis C VirusJournal of Immunoassay and Immunochemistry 2007; 29(1): 91 doi: 10.1080/15321810701735161
8
Ryohei Saga, Akira Fujimoto, Noriyuki Watanabe, Mami Matsuda, Makoto Hasegawa, Koichi Watashi, Hideki Aizaki, Noriko Nakamura, Shigeru Tajima, Tomohiko Takasaki, Eiji Konishi, Takanobu Kato, Michinori Kohara, Haruko Takeyama, Takaji Wakita, Ryosuke Suzuki. Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virusScientific Reports 2016; 6(1) doi: 10.1038/srep28688
9
Yalin Liao, Esmail El-Fakkarany, Bo Lönnerdal, Elrashdy M. Redwan. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells Journal of Medical Microbiology 2012; 61(3): 375 doi: 10.1099/jmm.0.033894-0
10
Mostafa K El Awady, Mohamed A Anany, Gamal Esmat, Naglaa Zayed, Ashraf A Tabll, Amr Helmy, Abdel Rahman El Zayady, Mohga S Abdalla, Hayat M Sharada, Maissa El Raziky, Wafaa El Akel, Shadia Abdalla, Noha G Bader El Din. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapyJournal of Gastroenterology and Hepatology 2011; 26(5): 843 doi: 10.1111/j.1440-1746.2010.06605.x
11
Tawfeek H. Abdelhafez, Noha G. Bader El Din, Ashraf A. Tabll, Mohammad M. Mashaly, Reham M. Dawood, Nemat A. Yassin, Mostafa K. El-Awady. Mice Antibody Response to Conserved Nonadjuvanted Multiple Antigenic Peptides Derived from E1/E2 Regions of Hepatitis C VirusViral Immunology 2017; 30(5): 359 doi: 10.1089/vim.2016.0123
12
Sidra Rehman, Bushra Ijaz, Nighat Fatima, Syed Aun Muhammad, Sheikh Riazuddin. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico studyBiomedicine & Pharmacotherapy 2016; 83: 881 doi: 10.1016/j.biopha.2016.08.002
13
B. Jammart, M. Michelet, E.-I. Pecheur, R. Parent, B. Bartosch, F. Zoulim, D. Durantel. Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 CellsJournal of Virology 2013; 87(9): 5065 doi: 10.1128/JVI.01405-12
14
Elrashdy M Redwan, Esmail M EL-Fakharany, Vladimir N Uversky, Mustafa H Linjawi. Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virusBMC Complementary and Alternative Medicine 2014; 14(1) doi: 10.1186/1472-6882-14-219
15
Maemu Petronella Gededzha, Maphahlanganye Jeffrey Mphahlele, Selokela Gloria Selabe. Characterization of HCV Genotype 5a Envelope Proteins: Implications for Vaccine Development and Therapeutic Entry TargetHepatitis Monthly 2014; 14(11) doi: 10.5812/hepatmon.23660
16
Mariam Mounir, Marwa Khalil Ibrahim, Reham M. Dawood, Ahmed B. Barakat, Mostafa K. El Awady. Establishment of serum derived infectivity coculture model for enhancement of hepatitis C virus replication in vitroHuman Antibodies 2019; 27(3): 185 doi: 10.3233/HAB-190370
17
Faiza Shams, Shazia Rafique, Sadia Zahid, Mobeen Munir, Muhammad Idrees, Muhammad Ilyas, Tayyab Husnain. Advances in the role of HCV nonstructural protein 5a (NS5A) of 3a genotype in inducing insulin resistance by possible phosphorylation of AKT/PKBScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-42602-2
18
Kai Deng, Zhanxue Xu, Mingxiao Chen, Xiaoxiang Liu, Enrique Ortega. Keyhole Limpet Hemocyanin-Conjugated Peptides from Hepatitis C Virus Glycoproteins Elicit Neutralizing Antibodies in BALB/c MiceJournal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/3108157
19
Jean-Christophe Meunier, Rodney S. Russell, Vera Goossens, Sofie Priem, Hugo Walter, Erik Depla, Ann Union, Kristina N. Faulk, Jens Bukh, Suzanne U. Emerson, Robert H. Purcell. Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C VirusJournal of Virology 2008; 82(2): 966 doi: 10.1128/JVI.01872-07
20
Mostafa K. El-Awady, Ashraf A. Tabll, Hassan Yousif, Yasmin El-Abd, Mohamed Reda, Samy B. Khalil, Abdel Rahman El-Zayadi, Maysa H. Shaker, Noha G. Bader El Din. Murine neutralizing antibody response and toxicity to synthetic peptides derived from E1 and E2 proteins of hepatitis C virusVaccine 2010; 28(52): 8338 doi: 10.1016/j.vaccine.2009.11.059